Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T O'Donnell

Showing results (81-90 of 245) with videos related to

Pageof 25
Sort By:
American Journal of Clinical Oncology|July 28, 2001
Treatment of vinorelbine-associated tumor painT D Long, R K Twillman, T A Cathers-Schiffman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
Practical determination of patient-specific marrow dose using radioactivity concentration in blood and bodyS Shen, G L DeNardo, G Sgouros, et al.
Neuropeptides|August 4, 2009
The role of beta-endorphin in the pathophysiology of major depressionK M Hegadoren, T O'Donnell, R Lanius, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2009
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenograftsRobert T O'Donnell, Yunpeng Ma, Hayes C McKnight, et al.
Transfusion|July 1, 1972
Aged human serum albumin: properties and clinical acceptibilityP Pappas, T O'Donnell, R B Pennell, et al.
Biomedicines|February 25, 2023
Expression of CISH, an Inhibitor of NK Cell Function, Increases in Association with Ovarian Cancer Development and ProgressionJasmin C Acosta, Janice M Bahr, Sanjib Basu, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2011
The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies aloneJoseph M Tuscano, Yunpeng Ma, Shiloh M Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse modelJoseph M Tuscano, Shiloh M Martin, Yunpeng Ma, et al.
Alternative Therapies in Health and Medicine|March 1, 1997
A scientific plan for the evaluation of alternative medicine in the treatment of HIV/AIDSL J Standish, C Calabrese, C Reeves, et al.
Waste Management (New York, N.Y.)|February 13, 2018
Case study comparison of functional vs. organic stability approaches for assessing threat potential at closed landfills in the USASean T O'Donnell, Michael D Caldwell, Morton A Barlaz, et al.
Pageof 25

Showing results (81-90 of 245) with videos related to

Sort By:
Pageof 25
American Journal of Clinical Oncology|July 28, 2001
Treatment of vinorelbine-associated tumor painT D Long, R K Twillman, T A Cathers-Schiffman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
Practical determination of patient-specific marrow dose using radioactivity concentration in blood and bodyS Shen, G L DeNardo, G Sgouros, et al.
Neuropeptides|August 4, 2009
The role of beta-endorphin in the pathophysiology of major depressionK M Hegadoren, T O'Donnell, R Lanius, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2009
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenograftsRobert T O'Donnell, Yunpeng Ma, Hayes C McKnight, et al.
Transfusion|July 1, 1972
Aged human serum albumin: properties and clinical acceptibilityP Pappas, T O'Donnell, R B Pennell, et al.
Biomedicines|February 25, 2023
Expression of CISH, an Inhibitor of NK Cell Function, Increases in Association with Ovarian Cancer Development and ProgressionJasmin C Acosta, Janice M Bahr, Sanjib Basu, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2011
The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies aloneJoseph M Tuscano, Yunpeng Ma, Shiloh M Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse modelJoseph M Tuscano, Shiloh M Martin, Yunpeng Ma, et al.
Alternative Therapies in Health and Medicine|March 1, 1997
A scientific plan for the evaluation of alternative medicine in the treatment of HIV/AIDSL J Standish, C Calabrese, C Reeves, et al.
Waste Management (New York, N.Y.)|February 13, 2018
Case study comparison of functional vs. organic stability approaches for assessing threat potential at closed landfills in the USASean T O'Donnell, Michael D Caldwell, Morton A Barlaz, et al.
Pageof 25